Testing three malaria medicines together versus two
Treatments studied
Part of Infections clinical trials.
This study compares a combination of three medicines to treat uncomplicated malaria, to see if it works as well and is as well tolerated as a two-medicine combination. You may join if you have a specific type of malaria infection in a mild form and meet safety requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can take medicine by mouth (swallow oral doses)
- You have fever (38°C or higher) or fever in the last 24 hours
- Malaria test shows uncomplicated Plasmodium falciparum infection (not severe)
- Your weight is at least 5 kg and you are age 6 months or older
- Recent malaria medicine use follows the timing rules (avoid certain drugs recently)
- You can follow the study visits and treatment plan for the full study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well and how safely different anti-malaria medicines work for people who have uncomplicated malaria caused by Plasmodium falciparum. You may be eligible if you have a confirmed infection with a certain parasite level and do not have signs of severe disease or major health conditions.
This study tests a new malaria treatment for children with mild (uncomplicated) malaria. The goal is to see if the treatment safely and effectively clears the infection.
This study tests how well malaria treatments work in Ethiopia. It aims to find the best medicines for uncomplicated malaria caused by certain parasites, helping patients recover fully and preventing future drug resistance.
This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.
This study tests a new combination of three malaria drugs in healthy adults to see how safe they are and how the body handles them. It helps find the right dose for future patients.
This study tests how well a malaria treatment plan works for people with P. vivax malaria who don’t have another malaria type at the same time. It aims to see whether adding or using different medicines (ACT vs chloroquine with tafenoquine) helps clear infection and prevent return of disease.
Hear when a new Uncomplicated Plasmodium Falciparum Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.